VIMS - Vidarbha Institute Of Medical Sciences

Details Doctors
Medical Suppliers In Maharashtra

Name :

VIMS Vidarbha Institute Of Medical Sciences

Address  :

Mohan Nagar, L. I. C. Square,
Kamptee Road

Town  :

Nagpur

State  :

Maharashtra

Country  :

INDIA

Post Code:

440001

Phone  :

0712-2811400-25

Web URL  :

Available

Email  :

info@vimsnagpur.com
VIMS Vidarbha Institute Of Medical Sciences

Doctors Of VIMS - Vidarbha Institute Of Medical Sciences
Physician
Qualification
Availability
Aarti Kalbande
Aarti Kalbande
M.B.B.S, M.D. (Obstetrics & Gynaecology)
Resident
Amit Dahat
Amit Dahat
M.B.B.S., M.D. (Pediatrics)
Resident
Ashish Badkhal
Ashish Badkhal
M.B.B.S., M.S., M.Ch. (CVTS, Gold Medalist)
Resident
Girish Thakre
Girish Thakre
M.B.B.S., D.A. (Anaesthesiology)
Resident
Hari Gupta
Hari Gupta
M.B.B.S, M.D. (Internal Medicine)
E.D.I.C. (European Diploma in Critical Care Medicine)
I.D.C.C.M. (Indian Diploma In Critical Care Medicine)
Resident
Juzar Ibrahimbhai Fidvi
Juzar Ibrahimbhai Fidvi
M.B.B.S, M.D. (Obstetrics & Gynaecology)
Resident
Minakshi Hande (Rewatkar)
Minakshi Hande (Rewatkar)
M.B.B.S., D.A., F.C.P.S. (Anaesthesiology)
Resident
Neha Badkhal (Bhatt)
Neha Badkhal (Bhatt)
M.B.B.S, M.D. (Pathology)
Resident
Nitin Khandelwal
Nitin Khandelwal
M.B.B.S, M.D. (Medicine)
Resident
Prafulla Borker
Prafulla Borker
M.B.B.S, M.S. (Orthopedics)
Resident
Sonali Thakre ( Malve)
Sonali Thakre ( Malve)
M.B.B.S, M.D. (Pathology)
Resident
Vinay Kalbande
Vinay Kalbande
M.B.B.S, D.O.R.L. (E.N.T.)
Resident
NEWS
Early detection can prevent most cancers from turning deadly report

Most cancers that kill Indians oral cavity breast cervical are preventable if detected at an early stage said doctors who conducted the study on cancerrelated deaths in India The study was published in The Lancet on Wednesday In 2010 23 of cancer deaths among men were because of oral cavity cancers Among women 17 of the deaths were because of ... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More